Skip to main navigation Skip to search Skip to main content

Mortality amongst European children with congenital anomalies: associations with socio-economic status in the EUROLINKCAT cohort

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Abstract

Background
Childhood mortality is affected by major congenital anomalies and socio-economic status (SES). To our knowledge, their combined impact has not been explored to age 10.
Methods
We analysed the population-based EUROlinkCAT cohort to ascertain the impact of SES on mortality by ages 1 and 10 amongst children with congenital anomalies in ten congenital anomaly registers in seven European countries. Four countries defined SES according to maternal education, and two used their national index of multiple deprivation. The ten registers used a common script to generate data on survival by ages 1 and 1-10 (3651 days). Eight registers analysed deaths according to their SES criteria, categorised as low, intermediate and high SES. Linked data were combined in random effects meta-analyses. Finland and Emilia-Romagna held data on single motherhood and EU-nationality.
Results
We analysed mortality in relation to SES using data on 47,134 live-born children with major congenital anomalies classified and recorded 1996-2014. Mortality by age 1 and ages 1-10 was higher amongst the most than the least deprived, hazard ratios (HR) and 95% confidence intervals (CI) 1.47, 1.19-1.83 and 2.00, 1.32-3.02. Differences between intermediate and least deprived groups were smaller. Differences were statistically significant for all four analyses only in Ukraine and Wales. Mortality rates were higher for children of non-EU nationals, but not single mothers.
Implications
Deprivation was more strongly associated with death at ages 1-10 than in infancy. These analyses of the most ill children in Europe indicate that, to achieve sustainable development goals, more resources are needed for the most vulnerable children
Original languageEnglish
Article numbere0352025
Pages (from-to)1-18
Number of pages18
JournalPLoS ONE
Volume21
Issue number8
Early online date5 Aug 2026
DOIs
Publication statusPublished (in print/issue) - 5 Aug 2026

Bibliographical note

© 2026 Jordan et al.

Data Availability Statement

All data related to these analyses are contained within the paper and supporting information. We are legally not allowed to share the third-party administrative data used in this study as it belongs to the data providers in each of the regions i.e. the regional or national statistical organisations. The study team had access to aggregate data only from each region i.e. the linked patient level data remained in the local region. The authors did not receive any special privileges in accessing the data, and were obliged to abide by the same rules and regulations pertaining to the data as other researchers. All the variables included in the study are found in the pdf for WP3 (Loane et al 2019). This includes the variable names, description, format, and coding scheme. All our documentation is available on the EUROlinkCAT website (http://www.EUROlinkCAT.eu/wp2-buildingresultsrepository). We encourage any interested parties to apply to the EUROlinkCAT management team to assist them in obtaining approval from the data providers in each region/ country to use the aggregated data for an approved study http://www.EUROlinkCAT.eu/contactinformationanddatarequests. The data that support the findings of this study are available from the participating registries of congenital anomalies, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors for scientifically valid requests and with permission of the participating registries of congenital anomalies. Data requests are via a non-author email: [email protected] or the corresponding authors. [email protected] or EUROlinkCAT - Establishing a linked European Cohort of Children with Congenital Anomalies.

Funding

This project received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733001 (Jan 2017 – Dec 2021) https://ec.europa.eu/programmes/horizon2020/en). / https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-2020_en The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, or review; and decision to submit the manuscript for publication. The views presented here are those of the authors only, and the European Commission is not responsible for any use that may be made of the information presented here. The authors have no potential conflicts of interest to disclose. No commercial companies were involved in this research. Funding was awarded to ML and the individual congenital anomaly registers. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, or review; and decision to submit the manuscript for publication. The views presented here are those of the authors only, and the European Commission is not responsible for any use that may be made of the information presented here.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Child Mortality
  • Cohort Studies
  • Congenital Abnormalities/mortality
  • Europe/epidemiology
  • Low Socioeconomic Status
  • Registries
  • Social Class
  • Socioeconomic Disparities in Health

Fingerprint

Dive into the research topics of 'Mortality amongst European children with congenital anomalies: associations with socio-economic status in the EUROLINKCAT cohort'. Together they form a unique fingerprint.

Cite this